Literature DB >> 10844413

Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes.

I S Kim1, E R Kim, H J Nam, M O Chin, Y H Moon, M R Oh, U C Yeo, S M Song, J S Kim, M R Uhm, N S Beck, D K Jin.   

Abstract

McCune-Albright syndrome (MAS) is a sporadic disease characterized by café-au-lait spots, polyostotic fibrous dysplasia and hyperfunctional endocrinopathies. To elucidate the mechanism of skin pigmentation, melanocytes, keratinocytes and fibroblasts were primary cultured from the café-au-lait spot of a MAS patient. Then, mutational analysis and morphologic evaluation were performed. Also, cAMP level and tyrosinase gene expression in cultured cells were determined. Only Gsalpha mutation was found in affected melanocytes and the cAMP level in affected melanocytes was higher than that of normal melanocytes. The mRNA expression of tyrosinase gene was increased in the affected melanocytes. This study suggests that skin pigmentation of MAS results from activating mutation of Gsalpha in melanocytes and the mechanism involves the c-AMP-mediated tyrosinase gene activation. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10844413     DOI: 10.1159/000023467

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  16 in total

Review 1.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

2.  Oral pigmentation in McCune-Albright syndrome.

Authors:  Dominique C Pichard; Alison M Boyce; Michael T Collins; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

3.  Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Authors:  Smita Jha; Nadja Fratzl-Zelman; Paul Roschger; Georgios Z Papadakis; Edward W Cowen; Heeseog Kang; Tanya J Lehky; Katharine Alter; Zuoming Deng; Aleksandra Ivovic; Lauren Flynn; James C Reynolds; Abhijit Dasgupta; Markku Miettinen; Eileen Lange; James Katz; Klaus Klaushofer; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  J Bone Miner Res       Date:  2018-09-14       Impact factor: 6.741

4.  Mucosal pigmentation caused by imatinib: report of three cases.

Authors:  Chia-Cheng Li; Salman M Malik; Bart F Blaeser; Walid J Dehni; Sadru P Kabani; Niamh Boyle; Mary Toner; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-12-31

5.  Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

Authors:  Young H Lim; Diana Ovejero; Jeffrey S Sugarman; Cynthia M C Deklotz; Ann Maruri; Lawrence F Eichenfield; Patrick K Kelley; Harald Jüppner; Michael Gottschalk; Cynthia J Tifft; Rachel I Gafni; Alison M Boyce; Edward W Cowen; Nisan Bhattacharyya; Lori C Guthrie; William A Gahl; Gretchen Golas; Erin C Loring; John D Overton; Shrikant M Mane; Richard P Lifton; Moise L Levy; Michael T Collins; Keith A Choate
Journal:  Hum Mol Genet       Date:  2013-09-04       Impact factor: 6.150

6.  A novel, complex heterozygous mutation within Gsalpha gene in patient with McCune-Albright syndrome.

Authors:  Huai-Dong Song; Feng-Ling Chen; Wen-Jing Shi; Shu Wang; Qun Zhang; Ren-Ming Hu; Jia-Lun Chen
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

7.  Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.

Authors:  Maria Zhadina; Kelly L Roszko; Raya E S Geels; Luis F de Castro; Michael T Collins; Alison M Boyce
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

8.  Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-27

Review 9.  McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.

Authors:  Michael T Collins; Frederick R Singer; Erica Eugster
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

10.  A high throughput screening assay system for the identification of small molecule inhibitors of gsp.

Authors:  Nisan Bhattacharyya; Xin Hu; Catherine Z Chen; Lesley A Mathews Griner; Wei Zheng; James Inglese; Christopher P Austin; Juan J Marugan; Noel Southall; Susanne Neumann; John K Northup; Marc Ferrer; Michael T Collins
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.